Hello, everyone, and how are you today? An extended spot of rain is falling on the Pharmalot corporate campus this morning, but perhaps you may recall what the Morning Mayor would say about such developments: Every brand new day should be unwrapped like a precious gift. So please join us in celebration with a delicious cup of stimulation. And while you do so, here are a few items to help you get started. Hope your day goes well and do stay in touch...
Pfizer To Sell Infant Nutrition Biz To Nestle For $11.9 Billion (Bloomberg News)
Amylin Hires Bankers To Explore A Sale (Reuters)
AstraZeneca To Buy Ardea BioSciences For $1.26 Billion (Bloomberg News)
Novartis Plans New Manufacturing Plant In Switzerland (MarketWatch)
PhRMA Worries About DTC Ad Deduction (Ad Age)
EMA's CHMP Issues Several Favorable Opinions (Pharma Times)
Roche Starts Talking To Illumina Rivals (Reuters)
Merck Invests $150M In R&D At Indian University (PharmaBiz)
Biota And Nabi Pharmaceuticals Plan To Merge (The Australian)
Covance Predicted To Cut Toxicology Capacity (Outsourcing Pharma)
Pakistan Suffers Raw Materials Problems (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates throughout the morning
rain pic thx to sterlic on flickr
1 Comment